Inflammatory Stress and Periodontal Tissue Destruction
2 other identifiers
observational
80
1 country
1
Brief Summary
Metabolic syndrome and periodontitis are diseases that lower the quality of life and their incidence rates are increasing. Since both of these diseases are associated with systemic inflammation and insulin resistance, they may be comorbid. The aim of this study was to evaluate the effect of interleukin-20 (IL-20) on periodontal destruction in individuals with metabolic syndrome while considering the relationship between metabolic syndrome and periodontitis. This study included a total of 80 individuals who were systemically and periodontally healthy (CG, n=20), were systemically healthy and had periodontitis (PG, n=20), had metabolic syndrome and were periodontally healthy (MG, n=20), or had both metabolic syndrome and periodontitis (MPG, n=20). Gingival crevicular fluid (GCF) and serum samples were collected from all participants for biochemical analyses.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 6, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 6, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 6, 2023
CompletedFirst Submitted
Initial submission to the registry
October 10, 2023
CompletedFirst Posted
Study publicly available on registry
October 23, 2023
CompletedOctober 23, 2023
October 1, 2023
9 months
October 10, 2023
October 16, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
concentration of gingival crevicular fluid (GCF) parameters
interleukin-20, RANKL, OPG values evaluated in GCF.
1 year
concentration of serum parameters
interleukin-20, RANKL, OPG, MMP-8, TOS, TAS values evaluated in serum
1 year
Secondary Outcomes (2)
value of periodontal clinical parameters
1 year
value of patients' clinical metabolic syndrome parameters
1 year
Study Arms (4)
systemically and periodontally healthy (CG)
Gingival crevicular fluid (GCF) and serum samples were collected from all participants for biochemical analyses.
systemically healthy and periodontitis (PG)
Gingival crevicular fluid (GCF) and serum samples were collected from all participants for biochemical analyses
Metabolic syndrome and periodontally healthy (MG)
Gingival crevicular fluid (GCF) and serum samples were collected from all participants for biochemical analyses
Metabolic syndrome and periodontitis (MPG)
Gingival crevicular fluid (GCF) and serum samples were collected from all participants for biochemical analyses
Interventions
Gingival crevicular fluid (GCF) and serum samples were collected from all participants for biochemical analyses
Eligibility Criteria
The sample size of the study was calculated using the G\*Power program with an effect size of 0.4, 80% power, and a margin of error of 0.05.
You may qualify if:
- all participants were required to have at least 20 teeth and be between the ages of 20 and 65 years
You may not qualify if:
- Smokers, patients who had used antibiotics or anti-inflammatory and antioxidant drugs in the last 6 months, patients who were pregnant or lactating, those who had cancer or autoimmune diseases, and those who had undergone any periodontal treatment in the last 6 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Recep Tayyip Erdogan University
Rize, Turkey (Türkiye)
Related Publications (1)
Senkal R, Yemenoglu H, Kose O, Karakas SM, Yilmaz A, Akyildiz K, Beder M, Bostan SA. The role of interleukin-20 on inflammatory stress and periodontal tissue destruction in patients with metabolic syndrome and periodontitis. BMC Oral Health. 2024 Nov 22;24(1):1423. doi: 10.1186/s12903-024-05224-3.
PMID: 39578819DERIVED
Biospecimen
plasma and gingival crevicular fluid
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Week
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- assistant professor
Study Record Dates
First Submitted
October 10, 2023
First Posted
October 23, 2023
Study Start
June 6, 2022
Primary Completion
March 6, 2023
Study Completion
June 6, 2023
Last Updated
October 23, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will not share